About
Jim Plante is an entrepreneur and investor best known as founder and managing partner of Thynk Capital, a venture firm focused on early-stage therapeutics, healthcare, and technology with a stated emphasis on healthspan and aging-related disease. He previously founded and led Pathway Genomics and SmartDrive Systems, and he is also associated with Klotho Therapeutics and Intelligent Medicine Exchange (IMX). His public profile also includes kidney-transplant advocacy through the Foundation for Kidney Transplant Research and U.S. federal advisory service in health/pharma trade policy.
Areas of interest
longevityhealthspan extensionbiotechtherapeuticshealthcaregenomicsartificial intelligenceaging-related diseasesalzheimerskidney diseasecancerdiabeteshealthcare derivativeshealthtech